UBS Group »

Design Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $133k 33k 4.03
2023-12-31 $134k 50k 2.65
2023-09-30 $43k 18k 2.36
2023-06-30 $152k 24k 6.30
2023-03-31 $1.2k 206 5.77
2022-12-31 $1.6M 156k 10.26
2022-03-31 $16k 998 16.03
2021-12-31 $999 35 28.57
2021-09-30 $17k 1.1k 14.99
2021-06-30 $10k 498 20.08
2021-03-31 $9.0k 300 30.00